Akt ratio in OC explants early after NF-B inhibition. Finally, we observed an early and consistent decrease in the phospho-p38/p38 ratio in OC explants exposed to the NF-B inhibitor and only a transient decrease in this ratio in OC examples after gentamicin exposure.
Introduction
Hearing loss due to sensorineural damage has been recognized for over a century. Until recently, damage to cochlear hair cells (HCs) and neurons has been regarded as an inevitable consequence of age, genetic conditions or exposure to certain environmental stimuli. During the past several years, however, some of the critical intracellular events that mediate aspects of damage to HCs have been discovered [Cheng et al., 2005; Matsui and Cotanche, 2004] . In a large number of studies, aminoglycosides have been utilized as inducers of HC death, and a significant progress in understanding aminoglycosideinduced HC death has been made [Lautermann et al., 2004; Rybak and Whitworth, 2005] . After aminoglycoside exposure, cellular and biochemical alterations in the HCs of the organ of Corti (OC) are set into motion. Reactive oxygen species have been detected in vitro soon after
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Abstract
Studies conducted over the last few years demonstrated that signaling pathways that operate in the organs of Corti (OC) play a central role in survival and death of hair cells. An important goal of molecular otology is to characterize these signaling pathways in normal inner ears and inner ears exposed to a variety of different forms of stress, such as ototoxic substances and noise overexposure. In this study, we used high-performance reverse protein microarray technology and phospho-specific antibodies to examine the activation status of defined molecules involved in cellular signaling. We demonstrate that reverse protein microarrays based on the highly sensitive planar-waveguide technology provide an effective and high-throughput means to assess the activation state of key molecules involved in apoptotic and prosurvival signaling in microdissected OC explants over time. In this study, we show that gentamicin and a specific NF-B inhibitor increase the ratio of phospho-c-Jun/c-Jun in OC explants of postnatal rats soon after exposure to these drugs. In addition, we found a decrease in the phospho-Akt/ exposure to aminoglycosides [Priuska and Schacht, 1995; Sha et al., 2001; Choung et al., 2009] . In addition, it has been demonstrated that small GTPases, such as Ras and Rho/Rac/Cdc42, as well as the c-Jun-N-terminal kinase (JNK) signaling pathway, are activated in cells exposed to the drug [Battaglia et al., 2003; Bodmer et al., 2002a, b; Pirvola et al., 2000; Jiang et al., 2006a] . JNK activation results in phosphorylation of c-Jun and in activation of the transcription factor activating protein-1 complex [Albinger et al., 2006; . Finally, caspases are activated and HCs undergo apoptotic cell death after prolonged aminoglycoside exposure [Huang et al., 2000; Okuda et al., 2005] . However, chronic administration of aminoglycosides induces also caspase-independent pathways of HC death [Jiang et al., 2006b] .
Interestingly, gentamicin exposure also activates pathways that promote HC survival [Battaglia et al., 2003] . This is in agreement with the current opinion that cells are thought to exist in a finely tuned balance between survival and cell death [Boatright and Salvesen, 2003; Raff, 1992] . According to this concept, exposure to cellular stress disrupts this balance and if the stress is severe, apoptosis-promoting pathways predominate and the cells die.
Lately, survival pathways which operate in HCs have been defined. One such pathway is the H-Ras/Raf/MEK/ Erk pathway [Battaglia et al., 2003] . Another pathway is the phosphatidylinositol-3 kinase (PI3k) pathway. In an interesting publication by Chung et al. [2006] , it has been shown that PI3k mediates HC survival and opposes gentamicin toxicity in neonatal rat OC explants via its downstream target, the protein kinase Akt. This finding is in good agreement with data from our laboratory. We demonstrated recently that the transcription factor NF-B is required for survival of immature auditory HC in vitro [Nagy et al., 2005 [Nagy et al., , 2007 in a PI3k-dependent pathway. In addition, in an interesting publication by Schacht and colleagues, it has been shown that the aminoglycoside kanamycin stimulates the activation of NF-B and that this activation protects cochlear HCs from aminoglycoside-induced ototoxicity [Jiang et al., 2005] .
Reversible protein phosphorylation is one of the most abundant posttranslational modifications. Protein kinases transfer a phosphate group from adenosine triphosphate to serine, threonine or tyrosine residues. This process is reversible, and dephosphorylation occurs by enzymes called phosphatases. Protein kinases and protein phosphatases are regulated by extracellular stimuli, and the activity of these enzymes leads to dynamic changes in protein phosphorylation and subsequently determines whether a signal transduction pathway is turned on or switched off. In order to gain insight into the molecular mechanisms involved in these processes, the phosphorylation status of key molecules involved in HC damage/death and survival need to be investigated. In this study, we used highly sensitive reverse protein microarrays which allow generating high-fidelity data for protein expression profiling of low levels or transient states of protein abundance [Pawlak et al., 2002; Weissenstein et al., 2006; Oostrum and Voshol, 2008] . We wanted to apply this new technology, namely planar-waveguide reverse protein microarrays, to the characterization and direct monitoring of the activity and protein phosphorylation of key molecules involved in apoptotic and prosurvival signaling in the OC. We hoped that the high sensitivity of the method would allow the parallel analysis of the phosphorylation status of several selected signaling marker proteins in single microdissected OC explants.
During the last decades, ELISAs have been used to measure the expression level of a defined single protein.
However, ELISA applications are often laborious, and time-and material-consuming. In contrast, protein arrays have the potential to analyze a multiple set of proteins simultaneously in only minute amounts of a biological sample. Protein arrays are mostly based on translating the well-established single-analyte ELISA assay format into a miniaturized, multiplexed assay combined with chemiluminescence or fluorescence readout [Tremplin et al., 2002] . In order to achieve adequate sensitivity for the signal detection, various amplification schemes have been developed. Zeptosens has developed a microarray system based on planar waveguide technology featuring an advanced surface-confined fluorescence signal generation and read-out scheme providing very high sensitivity while using less reagent and sample material compared to other microarray systems (www.zeptosens.com) [Pawlak et al., 2002] . While the inner ear offers only tiny amounts of tissue for analysis, we tested this protein array system for its potential use in inner ear research.
For the analysis, we chose two members of apoptosis signaling pathways (c-Jun and p38) and one member of a survival pathway (Akt). We investigated the ratios of the cellular levels of phosphorylated versus nonphosphorylated forms of the transcription factor c-Jun and of the protein kinase Akt over time in OC cultures exposed to either gentamicin or to an NF-B inhibitory peptide. In addition, we analyzed the expression levels of phosphorylated versus nonphosphorylated forms of p38, a protein kinase involved in apoptosis and cell survival pathways.
Material and Methods
Tissue Culture All animal procedures were carried out according to an approved animal research protocol (Kantonales Veterinaeramt, Basel, Switzerland). For tissue culture, 5-to 6-day-old Wistar rat pups were used. The rats were killed, and cochlear microdissections were performed under a light microscope to isolate the OC, spiral ganglion, and stria vascularis [Sobkowicz et al., 1993] . After isolation, all OCs were transferred to cell culture plates and maintained on 0.4-mm culture plate inserts (Millipore) in Dulbecco Modified Eagle Medium with 25 M HEPES supplemented with 10% fetal calf serum (all Invitrogen) and 30 U/ml penicillin (Sigma).
Gentamicin Time Course Experiment
OCs were obtained as described above. They were maintained for 48 h in culture medium for recovery. OCs were then exposed to gentamicin at the concentration of 0.5 m M for 2, 4, 6, 9, and 15 h. We recently demonstrated that this concentration of gentamicin results in significant HC loss after 15 h [Caelers et al., 2009] . Control explants were maintained in culture medium alone for 0 and 15 h. For each time point, 1 OC was studied. Each experiment was repeated three times for both conditions (culture medium alone or gentamicin treatment). After culturing, OC explants were lysed in 40 l of CLB96 buffer (Zeptosens).
NF-B Inhibition Time Course Experiment
To inhibit NF-B activity, an HPLC-purified synthetic inhibitor (NF-B inhibitor, AAVALLPAVLLALLAPVQRKRQKLMP, Santa Cruz Biotechnology, Inc., Santa Cruz, Calif., USA) was used at the final concentration of 25 g/ml in culture medium. We have previously shown that this compound at this concentration causes HC loss within several hours [Nagy et al., 2005] . OCs were obtained as described above. They were maintained for 48 h in culture medium for recovery. OCs were then exposed to the NF-B inhibitor at the concentration of 25 g/ml for 2, 6, and 15 h. Control explants were maintained in culture medium alone for 0 and 15 h. For each time point, 1 OC was studied. Each experiment was repeated three times for both conditions (culture medium alone or NF-B inhibitor treatment). After culturing, OC explants were lysed in 40 l of CLB96 buffer (Zeptosens).
Microarray Printing, Blocking, and Analysis
Microarrays were produced employing a standard protocol as described in detail [Oostrum et al., 2009] . Briefly, total protein lysates were spotted in serial fourfold dilutions on ZeptoMARK hydrophobic chips (Zeptosens) as droplets of 400 pl in duplicate with a noncontact piezoelectric microdispenser (Nanoplotter 2.0, GeSiM). Chips were dried for 1 h at 37 ° C and were blocked with blocking buffer BB1 for 20 min using the ZeptoFOG ultrasonic nebulizer (Zeptosens). After blocking, the chips were washed with water and spin-dried in a swinging-bucket centrifuge with an appropriate holder (available from Zeptosens) at 200 g for 3 min. The chips were stored at 4 ° C in the dark until use in reverse protein microarray assays. Each of the three biological replicates (independently treated OC explants) was analyzed in two independent microarray experiments.
For relative quantification of the immobilized proteins, chips were blocked with 1% Tween-80 in water following a similar protocol as described above. After the washing steps and drying, the chips were incubated with filtered Sypro Ruby Protein Dye (Invitrogen), diluted 1: 5 in water for 30 min and were washed again three times. Relative amounts of immobilized total protein lysates were quantified using the green detection channel ( ex/ em = 532/570 nm) of a ZeptoREADER (Zeptosens).
BB1-blocked chips were used for high-performance protein microarrays analysis. The chips were incubated with antibodies to phospho-(Thr308)-Akt, Akt, phospho-(Ser73)-c-Jun, c-Jun, phospho-(Thr180, Tyr182)-p38 MAPK and p38 MAPK in assay buffer CAB1 (Zeptosens) overnight. Then, after rinsing the chips with CAB1 three times, an incubation step with corresponding fluorophore-labeled anti-species antibodies (Alexa647-labeled rabbit or mouse Fab, Invitrogen Z25308 or Z25108, respectively) followed. After another wash cycle, protein phosphorylation was assessed by measuring fluorescence intensities in the red channel ( ex/ em = 635/670 nm) of a ZeptoREADER (Zeptosens). Images were analyzed with the ZeptoVIEW pro image processing software (version 2.0, Zeptosens), and relative fluorescence intensities were calculated by plotting of net spot intensities relative to protein concentration as described [Pawlak et al., 2002; Oostrum et al., 2009 ] and normalized to the relative amount of immobilized protein. Errors were calculated with Gauss' error progression.
ELISA Assay
An ELISA assay was used to quantify total Akt and phosphoAkt according to the manufacturer's protocol (R&D Systems). Briefly, all OC explants were maintained for 24 h in culture medium. Further, OC explants were cultured in fresh culture medium alone for 6 or 15 h (control), or were exposed to the NF-B inhibitor at the concentration of 25 g/ml for 6 or 15 h. The explants were then used for ELISA analysis to determine phosphoAkt and Akt in the two groups. The data were collected from four independent experiments and statistically analyzed (Student's t test).
Western Blot (Antibody Validation)
The following phospho-specific antibodies were tested for their selectivity for the phosphorylated epitope: phospho-(Thr308)-Akt, phospho-(Ser73)-c-Jun, phospho-(Thr180, Tyr182)-p38 MAPK. Antibodies were tested for specificity at a 1: 1000 dilution by Western Blotting as described [Towbin et al., 1979] using whole cell extracts from untreated, calyculin-treated (induction of Akt phosphorylation), UV-irradiated (induction of c-Jun phosphorylation) or anisomycin-treated (induction of p38 phosphorylation) HeLa cells according to a protocol by Zepto sens.
Results

Gentamicin Exposure or Exposure of OC Explants to the NF-B Inhibitor Results in an Increase in the Phospho-c-Jun/c-Jun Ratio
A time course analysis of the phospho-c-Jun to total c-Jun protein ratio reveals a significant increase in OC explants exposed to 0.5 m M gentamicin for 6 h ( fig. 1 a) or 2 h of the NF-B inhibitor at the concentration of 25 g/ ml ( fig. 1 b) , as compared to control explants. The peak ratio can be observed after 9 h of gentamicin exposure and 6 h of exposure to the NF-B inhibitor. Cell culturing itself does not change the phospho-c-Jun/c-Jun ratio, as we observe no difference when OC explants are held in culture medium alone (0 and 15 h).
Exposure of OC Explants to the NF-B Inhibitor Results in a Decrease in the Phospho-Akt/Akt Ratio and Gentamicin Exposure Does Not Change the Phospho-Akt/Akt Ratio over Time
A time course analysis of the phospho-Akt to total Akt protein ratio reveals a decrease in the phospho-Akt/Akt ratio in OC explants when exposed to the NF-B inhibitor for 2 and 6 h ( fig. 2 a) , with a minimum of the phospho-Akt/Akt ratio after 6 h of exposure as compared to control explants. An independent ELISA experiment confirmed the decrease in the phospho-Akt/Akt ratio in OC explants exposed to the NF-B inhibitor for 6 h as compared to control explants maintained in culture medium alone for 6 h ( fig. 3 ) . Exposure of OC explants to gentamicin does not change significantly the phosphoAkt/Akt ratio over time as revealed by the analysis of the array data ( fig. 2 b) or the ELISA analysis ( fig. 4 ) . Cell culturing itself does not change the phospho-Akt/Akt ratio, as we observe no difference when OC explants are held in culture medium alone (0 and 15 h).
Gentamicin Exposure or Exposure of OC Explants to the NF-B Inhibitor Results in an Early Decrease in the Phospho-p38/p38 Ratio
A time course analysis of the phospho-p38 to total p38 protein ratio reveals a significant decrease in the phosphop38/p38 ratio in OC explants exposed to 0.5 m M gentamicin for 4 h ( fig. 5 a) or the NF-B inhibitor at the concentration of 25 g/ml for 2, 6, and 15 h ( fig. 5 b) , as compared to control explants. The decrease in the ratio occurs early after gentamicin exposure (minimum after 4 h) or exposure to the NF-B inhibitor (minimum after 6 h). Interestingly, the phospho-p38/p38 ratio increases after the initial drop in the gentamicin-treated samples, while the samples treated with the NF-B inhibitor display a permanent decrease in the ratio over time. Cell culturing itself also changes the phospho-p38/p38 ratio, as we observe a decrease in the ratio when OC explants are held in culture medium alone for differing lengths (0 and 15 h). 
Anti-Phospho Antibodies Used Detect a Single Species in Western Blots
Western blot analysis revealed that the antibodies used in this study (antibodies against phospho-c-Jun, phospho-Akt, phospho-p38) detect just a single species ( fig. 6 ).
Discussion
The goal of this study was to investigate whether the planar-waveguide reverse protein microarrays can be used as a tool to analyze signal transduction events upon damage in the OC. The advantage of this new technology is that it is highly sensitive, so that a single OC can be probed with multiple antibodies. Therefore, precious material can be saved and fewer animals have to be sacrificed. A further advantage of this method is that even transient modifications of proteins, such as phosphoproteins, can be analyzed. However, the analysis of phosphoproteins is based on phospho-specific antibodies that are sometimes insensitive to cross-reactivity since the sequence around the phosphorylated residue is highly conserved. To demonstrate that the phospho-specific antibodies used in this study are specific, we used Western blots to show that the antibodies used detect a single species ( fig. 6 ). In the literature so far, several pathways have been implicated in damage to the OC. Here, we have used this new method to study some of these pathways. It should be noted that our in vitro data presented here are limited to newborn rat pups, because only OCs from newborn animals can be used for tissue culture. However, the immature cochlea is an established model for the study of aminoglycoside toxicity [Pirvola et al., 2000] . Still, in vitro toxicity assessed in neonatal tissue may occur by different mechanisms than in vivo toxicity in adults. As an example, it has been demonstrated that high-dose aminoglycoside treatment in vitro can lead to rapid blebbing of the apical HC surface [Richardson and Russel, 1991] . This phenomenon has not been observed in vivo . Therefore, we used relatively low gentamicin dosages (0.5 m M ) to mimic features of adult in vivo toxicity.
In line with the literature, the data of the present study demonstrate that the JNK pathway is involved in HC loss due to aminoglycoside gentamicin. Since JNK activation results in phosphorylation of c-Jun in HC nuclei [Bodmer et al., 2002a, b; Pirvola et al., 2000] , we used this pathway as a reference to test whether our array data would demonstrate the same findings. We show that the phosphorylated c-Jun to c-Jun ratio increases in OC explants exposed to 0.5 m M gentamicin for 6 and 9 h ( fig. 1 ). This observation is in good agreement with the literature [Matsui and Cotanche, 2004; Pirvola et al., 2000] . We observed a peak of phosphorylated c-Jun/c-Jun in OC explants after 9 h of exposure to gentamicin. This fits well with our previous observation that phosphorylated c-Jun can be seen in outer and inner HCs of the OC 12 h after gentamicin exposure using immunohistochemistry [Bodmer et al., 2002a] . Cell culturing of OC explants in medium alone does not seem to activate the JNK signaling pathway, as we observed the same ratio of phosphoc-Jun/c-Jun after culturing OC explants for 0 and 15 h without gentamicin treatment ( fig. 1 a) . NF-B inhibition also led to activation of the JNK signaling pathway: we observed an increase in phosphorylated c-Jun/c-Jun in OC explants after 6 h of NF-B inhibition as compared to control OC explants maintained in culture medium alone ( fig. 1 b) . Taken together, our results concerning the JNK pathway are in good agreement with the literature, and therefore suggest that this new technology is a powerful tool for the analysis of signaling events in cultured OC explants.
We have previously shown that NF-B inhibition results in rapid HC loss from cultured OC explants [Nagy et al., 2005] . In a follow-up study using gene arrays and a biochemical assay, we were able to link the NF-B-induced HC loss to PI3k [Nagy et al., 2007] . Interestingly, the PI3k pathway has been previously linked to HC survival [Chung et al., 2006] and to aminoglycosides [Schacht et al., 1977; Jiang et al., 2006c] . Activated PI3k phosphorylates the membrane lipid PIP2 at the 3 -OH position to generate PIP3. PIP3 recruits signaling proteins such as Akt and PDK-1. The activation state of Akt is an indicator of the state of the PI3k survival pathway. In this study, we observed an early decrease in the phospho-Akt/Akt ratio in OC explants exposed to an NF-B inhibitor as compared to control OC explants maintained in cell culture medium alone ( fig. 2 a) . Using an ELISA analysis, we were able to confirm the protein microarray data: OC explants exposed to the NF-B inhibitor also demonstrated a decrease in the phospho-Akt/Akt ratio as compared to control explants maintained in culture medium alone for the same time period (6 h; fig. 3 ). The decrease was more significant with ELISA than it was with the array. It might be that this quantitative difference in the phospho-Akt/ Akt ratio using the two methods is due to the cross-reactivity that might have occurred using the ELISA kit or due to the possibility that ELISA might have been somewhat more sensitive in this particular case. In contrast to the situation in OC explants treated with the NF-B in- hibitor, we did not observe a difference in the ratio of phospho-Akt/Akt in OC explants treated with gentamicin ( fig. 2 b and 4 ) . Chung et al. [2006] observed a discrete increase in phospho-Akt after gentamicin exposure, as revealed by Western blot analysis. However, that study did not assess the phospho-Akt to Akt ratio and a different gentamicin concentration (0.05 vs. 0.5 m M gentamicin) was used. Taken together, previous reports and data from this study implicate that NF-B promotes HC survival via its downstream targets PI3k and Akt. Further on, we observed a significant decrease in the phospho-p38 to total p38 ratio in OC explants exposed either to gentamicin ( fig. 5 a) or to the NF-B inhibitor ( fig. 5 b) . However, this decrease was only transient after exposure to gentamicin. Wei et al. [2005] reported an increase in p38 phosphorylation after exposure of OC explants to gentamicin as revealed by immunohistochemistry. At first look, this report seems to contradict our finding. However, the ratio of phospho-p38 to total p38 in the control at 15 h in our experiment is also much lower compared to the control at 0 h, it is also lower than the ratio at 15 h after gentamicin exposure. Since Wei et al. [2005] have performed the experiment at 16 h, it might be extrapolated from our graph in figure 5 a, assuming that there is a continuous drop in the ratio of phospho-p38 to total p38 in the control explants over the whole time course of 15 h, that at that time point there was an increase in p38 phosphorylation in the explants exposed to gentamicin when compared to the control explants. It seems that phospho-p38 is very unstable as its level is very much reduced in the control at 15 h. Still, the drop is even more significant at 4 h after gentamicin exposure. It is hard to interpret the presented data, but perhaps it might be concluded that as the immediate response to gentamicin, phospho-p38 is dephosphorylated and the longer exposure to gentamicin triggers its phosphorylation.
The decrease in phospho-p38/p38 after exposure to the NF-B inhibitor was more significant and was measured at all time points, indicating that the NF-B inhibitor induces dephosphorylation of phospho-p38.
Overall, this study shows that the new technology of reverse phase protein microarray can be very useful for analyzing the signal transduction pathways in the damaged OC. The presented data confirm some of the published findings and reveal new ones. However, one has to keep in mind that this new method, as any other method used so far for the analysis of events in the OC, is limited by the fact that numerous cell types in the OC make it difficult to discern differences in cell type-specific expression. Since our analysis is based on whole OC cultures, our data reflect protein level and phosphorylation changes from all the cells that compose the OC, among which are HCs, but also various supporting cells. However, we know from previous studies that the signaling pathways described in this article operate in HCs of the OC. Our group demonstrated that gentamicin treatment results in increased phospho-c-Jun staining of HC nuclei and no staining of supporting cell could be observed [Bodmer et al., 2002a, b] . Likewise, it has been shown that gentamicin induces phosphorylation of p38 in HCs and not in supporting cells of the OC [Wei et al., 2005] . Finally, aminoglycoside exposure of mice in vivo results in decreased phospho-Akt staining of HCs, whereas no staining could be observed in the supporting cells of the OC [Jiang et al., 2006c] .
This method can prove useful for other purposes as well, as besides analyzing intracellular events involved in damage of HCs in the OC, it might be used for profiling of cytokine expression during inflammation of the inner ear or for detecting proteins which are expressed in low levels in inner ear tissue.
